$1.28
0.000.00%
Comments
Loading...
Acumen Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:ABOS | Benzinga
Acumen Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 25
EPS Estimate
$-0.400
Quarterly Revenue Estimate
–
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Acumen Pharmaceuticals using advanced sorting and filters.
Data brought to you by Benzinga APIs
Acumen Pharmaceuticals (ABOS) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-12 | $-0.50 | $-0.36 | -38.9 % |
| Q2 | 2024-08-13 | $-0.34 | $-0.28 | -21.4 % |
| Q1 | 2024-05-14 | $-0.25 | $-0.26 | 3.85 % |
| Q4 | 2024-03-26 | $-0.29 | $-0.26 | -11.5 % |
Acumen Pharmaceuticals (ABOS) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Acumen Pharmaceuticals (NASDAQ:ABOS) reporting earnings?
Acumen Pharmaceuticals (ABOS) is scheduled to report earnings on May 13, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
What were the latest earnings per share (EPS) for Acumen Pharmaceuticals (NASDAQ:ABOS)?
The Actual EPS was $-0.50, which missed the estimate of $-0.36.
What were Acumen Pharmaceuticals’s (NASDAQ:ABOS) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.